The European Foundation for the Care of Newborn Infants (EFCNI) is the official Patient and Public Involvement (PPI) partner of the TREOCAPA study. What is EFCNI? The European Foundation for the Care of Newborn Infants (EFCNI) is a pan-European organisation and network which represents the interests of preterm and newborn infants and their families. Its… Continue reading EFCNI: European Foundation for the Care of Newborn Infants
TREOCAPA: an international trial conducted in more than 60 centres of 17 European countries. TREOCAPA tries to find out whether the preventive use of paracetamol in preterm infants during the first five days of life is safe and effective to close the ductus arteriosus blood vessel and reduces the risk of prematurity associated complications.